Literature DB >> 27073262

A model for predicting prolonged length of stay in patients undergoing anatomical lung resection: a National Surgical Quality Improvement Program (NSQIP) database study.

Matthew R DeLuzio1, Hari B Keshava2, Zuoheng Wang3, Daniel J Boffa4, Frank C Detterbeck4, Anthony W Kim5.   

Abstract

OBJECTIVES: There are currently no studies that have specifically delineated the risk factors for a prolonged length of hospitalization in patients undergoing anatomical lung resection. Knowing these risk factors is important in terms of risk stratification and improving outcomes in the high-risk population. The goal of this study was to identify risk factors associated with a prolonged length of stay (≥14 days) in patients undergoing an anatomical lung resection and to further create a model for predicting the probability of a prolonged length of stay in these patients.
METHODS: The NSQIP database (2005-2013) was culled for data on 45 distinct preoperative, intraoperative and postoperative variables among patients undergoing anatomical pulmonary resections. Univariate and multivariate logistic regression analyses were used to determine variables that contributed to a prolonged length of stay. A scoring system was created based on these results and applied to internal and external (a single institution database) validation groups to test for the adequacy of the model through the comparison of receiver operating characteristic curves.
RESULTS: Fifteen factors were found to be significant for prolonged length of stay; six were preoperative (age >70 years [P < 0.0001], functional status-dependent [P = 0.0020], chronic obstructive pulmonary disease [P < 0.0001], serum sodium <135 mmol/l [P = 0.0200], ASA Class 3 [P = 0.0070] and ASA Class 4 or 5 [P = 0.0010]), one was intraoperative (open thoracotomy [P < 0.0001]) and eight were postoperative (pneumonia [P < 0.0001], unplanned reintubation [P < 0.0001], prolonged mechanical ventilation [P < 0.0001], urinary tract infection [P < 0.0001], stroke [P = 0.0020], transfusion [P = 0.0010], deep vein thrombosis/thrombophlebitis [P < 0.0001] and return to the operating room [P < 0.0001]).
CONCLUSIONS: A simple model for predicting the probability of a prolonged length of stay in patients undergoing anatomical lung resection has been successfully created. This model can allow for better risk stratification of patients preoperatively based on certain existing comorbidities, and can help to predict the impact the development of various postoperative complications will have on overall patient outcomes.
© The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Length of stay; Lung surgery; Score

Mesh:

Year:  2016        PMID: 27073262     DOI: 10.1093/icvts/ivw090

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  4 in total

1.  Development and validation of nomogram estimating post-surgery hospital stay of lung cancer patients: relevance for predictive, preventive, and personalized healthcare strategies.

Authors:  Xiang-Lin Hu; Song-Tao Xu; Xiao-Cen Wang; Jin-Long Luo; Dong-Ni Hou; Xiao-Min Zhang; Chen Bao; Dong Yang; Yuan-Lin Song; Chun-Xue Bai
Journal:  EPMA J       Date:  2019-05-08       Impact factor: 6.543

2.  Predictive model of length of stay and discharge destination in neuroscience admissions.

Authors:  M M Stecker; M Stecker; J Falotico
Journal:  Surg Neurol Int       Date:  2017-02-06

3.  Development of a scoring tool for predicting prolonged length of hospital stay in peritoneal dialysis patients through data mining.

Authors:  Jingyi Wu; Guilan Kong; Yu Lin; Hong Chu; Chao Yang; Ying Shi; Haibo Wang; Luxia Zhang
Journal:  Ann Transl Med       Date:  2020-11

4.  Sugammadex is associated with shorter hospital length of stay after open lobectomy for lung cancer: a retrospective observational study.

Authors:  Seung Won Song; Kyung Yeon Yoo; Yong Sung Ro; Taehee Pyeon; Hong-Beom Bae; Joungmin Kim
Journal:  J Cardiothorac Surg       Date:  2021-03-23       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.